11days left

Starting 28 January 2021

Save your spot

ARCHE & pIEt Consulting 9th BPR FORTNIGHT 2021

Online Symposium




Our 9th annual BPR Symposium was scheduled on November 5th 2020 in Brussels. Due to the rather exceptional circumstances we reinvented our successful event. We have come up with an alternative solution which we trust will make you not miss out on the experience!

Why attend?

With the challenges of online conferences in mind we have chosen to spread our different subjects and speakers over a period of 14 days, a fortnight. This gives you the opportunity to keep an optimal focus over the different subjects and provides the additional benefit to be more selective in the subjects that you are interested in, since you will be able to subscribe for each topic separately. We will kick off our Fortnight with an online training, for which you can also separately subscribe.


Our ARCHE & pIEt Consulting BPR FORTNIGHT will be held online from 28 January 2021 until 11 February 2021. The dates and subjects are listed below, all webinars start at 14:00 CET and are scheduled for one hour.

  • 28/01/2021 – Start to BPR (training) – ARCHE Consulting
    • What do hand sanitising gels, industrial preservatives, mosquito repellent sprays and antifouling paints for sea-going vessels have in common? The making available on the market of all these (and other) products is regulated by the Biocidal Products Regulation (EU) No 528/2012, abbreviated BPR).
      The BPR imposes strict requirements on biocidal products throughout the EU territory, from composition to labelling to promotion. Producing and selling biocidal products in accordance with the BPR is not easy, but the BPR also offers opportunities for those who know its functioning well.
      This EU legislation is being rolled out gradually and more and more products are coming within its scope. It is very important for users, manufacturers and distributors of biocides to be well prepared when their products are fully covered by the BPR rules. For many products, this means anything but ‘business as usual’. Being unprepared may cause a serious disruption of your business.
  • 02/02/2021 – Efficacy requirements for PT18/19 (insecticides and repellents/attractants) – Judeel B.V. and pIEt Consulting
    • Find your way in the different guidance documents, standard tests and protocols related to efficacy testing
    • How representative are laboratory and simulated use efficacy tests in relation to the real world applications?
    • What do we know about repellents and attractants for mammals?
    • Dosing and application methods of insecticides for the general public.
  • 04/02/2021 – Emerging challenges (anti-microbial resistance, ED assessments,…) – ARCHE Consulting
    • While biocides are vital instruments to kill or inhibit bacteria in a multitude of conditions, their use is also associated with a risk of the emergence and selection of antimicrobial resistance (AMR) in target organisms. Additionally, cross-resistance and co-resistance can occur against other biocides and even antibiotics, further increasing potential health and environmental risks. Although the BPR declares such a resistance phenomenon as an unacceptable effect for biocidal products, no clear guidelines are given to address this issue in practice. A recent report by ANSES (FR) on the resistance to antimicrobial biocides may have set the stage for the development of such future guidelines at the European level.
    • ED or not ED, that’s the question! The answer might be simple, but the assessment underlying the identification of a biocide as an endocrine disruptor (ED) is not that easy. The strategy provided in the guidance requires a lot of knowledge and data. An adverse effect of an ED has to be linked to an endocrine mode of action (MoA) in a weight of evidence approach (WoE). If it seems that information has to be generated, this might imply that expensive and time-consuming tests need to be performed. In times where BPR annexes are being updated, where test methods are still under development, and where adverse outcome pathways (AOPs) still need to be unravelled, ED assessment is indeed challenging!
  • 09/02/2021 – Regulatory updates (Brexit,…) – Fieldfisher and ARCHE Consulting
    • The UK has finally (and sadly) left the EU and there are no more transition periods where EU law is applied. What does that mean for companies in the biocides market and what HSE deadlines are relevant for them? Can they already take actions now to ensure they are best placed to meet these HSE deadlines? What about the situation in Northern Ireland?
      On COVID-19, what is the situation for the hand gel derogations that EU authorities have enacted? Will they continue? And what should companies marketing treated articles in the fight against COVID-19 need to know regarding the approach of biocidal enforcement authorities?
  • 11/02/2021 – Business under BPR (Article 95 list, BPF,…) – Christeyns and ARCHE Consulting
    • Lessons learned and practical tips for surviving the BPR from a business perspective.
    • Based on our extensive experience with consortia and the building of families we at ARCHE Consulting have reconsidered this year the way our the consortia are established. The Note for Guidance ‘Implementing the concept of biocidal product family’ was put into force and this new family concept has forced everyone to reevaluate the way Biocidal Product Families are formed. The narrowed BPF concept and the subsequent stricter eCa’s are is new to all the players on the market and will certainly be a challenge. Based on the knowledge build up over the years we navigate through these new and unforeseeable factors with an open mind and an adjusted consortium structure. We will share our first thoughts and experiences about this new adventure in our webinar.

For the different topics ARCHE & pIEt Consulting and external experts will share there insights. Time for Q&A will also be foreseen.

Who will benefit from this symposium?

Anyone involved in the placing on the market of biocidal products or active substances, who wants to remain compliant with the legislation and is active in regulatory affairs, R&D or marketing.


Registration fees are listed below with a minimum choice of 2 webinars. Early bird fees available until 15/01/2021.

  • 2 webinars: 190 euro (excl. VAT) – early bird: 150 euro (excl. VAT)
  • 3 webinars: 280 euro (excl. VAT) – early bird: 220 euro (excl. VAT)
  • 4 webinars: 370 euro (excl. VAT) – early bird: 290 euro (excl. VAT)
  • 5 webinars: 450 euro (excl. VAT) – early bird: 350 euro (excl. VAT)

In case several colleagues from the same company are interested in joining our webinars, a 50% discount is provided from the second registration onwards.